一个移动解决方案的共同设计,开发和评估,以改善癌症患者的药物坚持:设计科学研究方法
Thu Ha Dang1,2,3, Nilmini Wickramasinghe4,5,6,7, Abdur Rahim Mohammad Forkan8
1Department of Psychological Sciences, School of Health Sciences, Swinburne University of Technology, Melbourne, Australia.
JMIR cancer
|April 3, 2024
概括
一个新的移动健康解决方案,安全和药物坚持和瘤学自我护理建议 (SAMSON),是共同设计的,以改善癌症患者的药物坚持. 初步评估表明,SAMSON是可用的,有吸引力的,并可能有效地支持坚持.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 在瘤学瘤学.
- 行为科学 行为科学
背景情况:
- 癌症患者不坚持药物治疗导致健康状况不佳和成本增加.
- 数字技术提供了潜在的解决方案,但对有效干预设计的证据有限.
- 开发以患者为中心的数字工具对于改善癌症护理至关重要.
研究的目的:
- 共同设计,开发和初步评估瘤学 (SAMSON) 移动健康解决方案的安全性和药物遵守性和自我护理建议.
- 解决有效的数字干预措施的需求,以改善癌症患者的药物坚持.
- 将行为科学原则集成到以患者为中心的数字工具中.
主要方法:
- 设计科学研究方法 (4个周期,6个过程) 用于开发.
- 文献和系统评论为设计特征的概念化提供了信息.
- 一项为期6周的混合方法研究评估了SAMSON移动溶液与患者.
主要成果:
- 萨姆森解决方案包括一个移动应用程序,网络门户和数据库,其中包含提醒,症状跟踪和报告的模块.
- 定量数据 (n=30) 显示SAMSON易于使用 (78%),引人入胜 (67%) 和组织良好 (70%).
- 定性数据 (n=25) 表示患者发现SAMSON对提醒,支持和信息有帮助,尽管应用程序故障和技术缺乏经验被认为是障碍.
结论:
- 该研究成功地应用了设计科学和行为科学,开发了一个以患者为中心的移动解决方案,用于癌症中药物坚持.
- 严格的方法对于在瘤学中创建有效的数字干预措施至关重要.
- 进一步的代将包括基于用户反的技术改进和设计增强.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345


